United States Ultrasound Device Market is expected to reach US$ 4.32 billion by 2034 from US$ 2.73 billion in 2025, with a CAGR of 5.23% from 2026 to 2034. Rapid adoption of portable and point-of-care ultrasound systems, rising chronic disease prevalence, and increasing use of AI-enhanced imaging are key drivers. Strong healthcare spending and preference for non-invasive diagnostics further accelerate U.S. ultrasound device market growth.
Growth of the U.S. ultrasound device market is driven by increasing demand for non-invasive diagnostic imaging, fueled by rising cases of cardiovascular disorders, cancer, and musculoskeletal conditions. The expansion of point-of-care ultrasound in emergency departments, critical care, ambulances, and primary clinics further accelerates adoption. Technological advancements - particularly AI-powered image analysis, 3D/4D imaging, and portable handheld devices - improve diagnostic speed and accuracy. Strong healthcare spending, a growing elderly population, and favorable reimbursement policies contribute to widespread usage. The shift toward decentralized healthcare and telemedicine also boosts demand for portable ultrasound systems to support remote diagnosis and patient monitoring.
United States Ultrasound Device Industry Overview
Ultrasound devices in the United States are medical imaging systems that use high-frequency sound waves to capture real-time images of internal organs, tissues, and blood flow. They are widely used across medical specialties including obstetrics, cardiology, oncology, emergency medicine, and primary care. These devices range from large cart-based systems to compact, handheld ultrasound probes that connect to smartphones or tablets. Ultrasound is valued for being safe, non-invasive, radiation-free, and cost-effective compared with other imaging modalities. Recent innovations such as 3D/4D imaging, AI-guided measurements, and wireless connectivity have expanded clinical applications and improved workflow efficiency in hospitals and outpatient facilities.Growth of the U.S. ultrasound device market is driven by increasing demand for non-invasive diagnostic imaging, fueled by rising cases of cardiovascular disorders, cancer, and musculoskeletal conditions. The expansion of point-of-care ultrasound in emergency departments, critical care, ambulances, and primary clinics further accelerates adoption. Technological advancements - particularly AI-powered image analysis, 3D/4D imaging, and portable handheld devices - improve diagnostic speed and accuracy. Strong healthcare spending, a growing elderly population, and favorable reimbursement policies contribute to widespread usage. The shift toward decentralized healthcare and telemedicine also boosts demand for portable ultrasound systems to support remote diagnosis and patient monitoring.
Growth Drivers for the United States Ultrasound Device Market
Technological Innovation and AI Integration
Ongoing technological advancements significantly propel the U.S. ultrasound device market. Modern ultrasound systems increasingly incorporate artificial intelligence to automate image interpretation, enhance accuracy, and reduce operator dependency. AI-assisted tools can automatically detect abnormalities, measure anatomical structures, and optimize imaging settings, improving clinical efficiency. The rise of portable and handheld ultrasound devices allows clinicians to perform real-time diagnostics at the patient’s bedside, in ambulances, and even in remote locations. Enhanced 3D/4D imaging technologies support clearer visualization for obstetric, cardiac, and musculoskeletal assessments. Wireless connectivity, cloud storage, and smartphone-compatible probes enable rapid data sharing and remote consultations. By combining hardware innovation with intelligent software, ultrasound devices have become more versatile, user-friendly, and efficient. These advancements support broader adoption across emergency medicine, primary care, outpatient clinics, and home health services, greatly expanding the overall market potential.Increasing Chronic Diseases and an Aging Population
Rising chronic illnesses and a growing elderly population substantially increase the need for ultrasound imaging across the United States. Conditions such as heart disease, diabetes-related complications, cancer, and vascular disorders require frequent imaging for diagnosis, monitoring, and treatment planning. Ultrasound is particularly favored due to its safety, speed, and affordability, making it ideal for repeated assessments. The expanding elderly demographic - more susceptible to cardiac, renal, and musculoskeletal issues - drives higher imaging volumes. Additionally, ultrasound plays a central role in women’s health, including prenatal care, reproductive health monitoring, and breast imaging. As preventive healthcare becomes more prioritized, routine screenings for abdominal, thyroid, and vascular conditions are increasingly performed using ultrasound. These population-driven healthcare needs significantly boost demand for advanced imaging technologies and portable systems across hospitals, diagnostic centers, and outpatient care facilities.Expansion of Point-of-Care Ultrasound (POCUS)
Point-of-care ultrasound is transforming medical practice in the U.S. by bringing diagnostic imaging directly to the patient, reducing delays and improving decision-making. POCUS is now widely used in emergency medicine, critical care, trauma centers, family practice, and anesthesia. Clinicians value its ability to provide immediate visual information that guides procedures, triage decisions, and bedside evaluations. Handheld devices enable portability, allowing use in ambulances, rural clinics, and home care environments. The integration of wireless probes, cloud-based documentation, and tele-ultrasound enables specialists to remotely guide imaging or interpret results. As healthcare shifts toward decentralized, value-based care, POCUS supports faster diagnosis, reduced hospital admissions, and better patient outcomes. These benefits drive strong demand for compact, portable, and affordable ultrasound systems across the country.Challenges in the United States Ultrasound Device Market
Regulatory and Integration Limitations
Regulatory complexity is a significant challenge in the U.S. ultrasound device market. AI-enhanced systems require rigorous validation and lengthy regulatory review, slowing the introduction of new features and upgrades. Smaller manufacturers may struggle with compliance costs and documentation requirements. Interoperability issues also limit seamless integration of ultrasound data with electronic health records, affecting workflow efficiency. Lack of standardized data formats can impede the use of advanced analytics and longitudinal patient monitoring. Additionally, ensuring cybersecurity for connected devices remains a growing concern, requiring ongoing software updates and security measures. These barriers collectively slow innovation, increase operational costs, and complicate the adoption of advanced ultrasound technologies.Competition From Advanced Imaging Modalities
Ultrasound devices face competition from higher-resolution imaging technologies such as CT, MRI, and PET, which offer superior anatomical detail for complex diagnostic needs. In specialties like oncology, neurology, and advanced cardiology, clinicians may prefer these modalities for definitive assessments. This reduces ultrasound utilization in certain high-precision diagnostic areas. Furthermore, premium ultrasound systems equipped with advanced features can be costly, posing affordability challenges for smaller clinics and rural health providers. Variability in reimbursement rates and high maintenance costs can also discourage investment in newer systems. These competitive and financial pressures limit market expansion and influence purchasing decisions across healthcare facilities.California Ultrasound Device Market
California’s ultrasound device market is strengthened by its advanced healthcare infrastructure, large patient population, and high adoption of innovative imaging technologies. Major medical centers in Los Angeles, San Francisco, and San Diego rely heavily on ultrasound for cardiology, obstetrics, oncology, and emergency care. The state’s leadership in medical research and technology encourages early adoption of AI-driven imaging tools and handheld ultrasound devices. Telemedicine growth and mobile healthcare programs expand ultrasound use in rural and underserved communities. California’s sizable elderly population and rising chronic disease rates create sustained demand for diagnostic imaging. Strong healthcare investment and reimbursement support further promote rapid deployment of advanced ultrasound systems across hospitals and outpatient facilities.Texas Ultrasound Device Market
Texas has a rapidly expanding ultrasound device market driven by its growing healthcare infrastructure and large, diverse population. Medical hubs in Houston, Dallas-Fort Worth, and Austin utilize ultrasound extensively across cardiology, obstetrics, trauma care, and primary care. High rates of chronic diseases such as diabetes and cardiovascular disorders increase demand for frequent diagnostic imaging. Rural areas also benefit from portable and handheld ultrasound systems, improving access to care. The state’s fast-growing outpatient centers, urgent care clinics, and telehealth programs incorporate ultrasound to streamline diagnostics and reduce patient wait times. Strong population growth, expanding healthcare networks, and increased investment in modern imaging technologies contribute to robust market development.New York Ultrasound Device Market
New York’s ultrasound device market is supported by world-leading medical institutions, extensive diagnostic networks, and a high volume of imaging procedures. Hospitals in New York City, Albany, and Buffalo frequently use ultrasound for cardiology, obstetrics, oncology, and emergency medicine. High patient throughput and a growing elderly population drive demand for efficient, accurate imaging tools. Adoption of advanced modalities such as 3D/4D imaging and AI-guided analysis is strong, supported by an innovation-driven healthcare environment. Outpatient imaging centers and telehealth programs also integrate portable ultrasound systems to expand service reach. Combined with strong reimbursement frameworks, these factors enable rapid adoption of new ultrasound technologies across the state.Florida Ultrasound Device Market
Florida’s ultrasound device market is propelled by its large aging population and high demand for diagnostic imaging related to cardiovascular, abdominal, and women’s health conditions. Major healthcare hubs in Miami, Orlando, and Tampa extensively use ultrasound for preventive screenings and chronic disease management. The state’s sizable retiree population increases utilization of vascular, cardiac, and musculoskeletal ultrasound services. Growing outpatient facilities, urgent care centers, and home health programs rely on portable and handheld devices to support rapid diagnostics. Florida’s strong medical tourism sector and expanding healthcare investments further promote adoption of advanced ultrasound systems. Favorable reimbursement and increasing telemedicine adoption also contribute to sustained market growth.Recent Developments in United States Ultrasound Device Market
- March 2025: MedShare, together with Becton, Dickinson (BD) and Company and the National Association of Free and Charitable Clinics, supplied 92 new portable ultrasound units to free and safety-net clinics across 30 U.S. states. This large-scale donation significantly expands diagnostic imaging access for underserved groups, especially in rural and low-income communities that often lack advanced medical equipment.
- March 2025: Vave Health introduced a wireless, handheld ultrasound device designed for whole-body imaging and powered by a single PZT transducer. The new system aims to improve diagnostic accuracy, efficiency, and mobility in both clinical and educational environments, addressing the rising demand for compact and versatile imaging tools.
- March 2025: GE HealthCare launched its Automated Breast Ultrasound Premium platform, integrating advanced AI to provide faster and more consistent supplemental breast screenings. The system is designed to improve diagnostic precision, particularly for patients with dense breast tissue, supporting improved workflow and enhanced imaging outcomes.
- January 2025: The U.S. FDA granted 510(k) clearance for GE HealthCare’s upgraded Voluson Expert Series, including the Voluson Expert 22, 20, and 18 models. These approvals reaffirm the devices’ safety and performance, enabling broader clinical adoption and contributing to ongoing innovation in the ultrasound market.
Market Segmentation
Products
- Diagnostics Ultrasound
- Therapeutic Ultrasound
Portability
- Trolley/Cart-based Ultrasound Devices
- Compact/Handheld Ultrasound Devices
Application
- Radiology/General Imaging
- Cardiology
- Gynecology
- Vascular
- Urology
- Others
End-Users
- Hospitals
- Surgical Centers
- Diagnostic Centers
- Maternity Centers
- Ambulatory Care Centers
- Academic Institutions
Top States
- California
- Texas
- New York
- Florida
- Illinois
- Pennsylvania
- Ohio
- Georgia
- New Jersey
- Washington
- North Carolina
- Massachusetts
- Virginia
- Michigan
- Maryland
- Colorado
- Tennessee
- Indiana
- Arizona
- Minnesota
- Wisconsin
- Missouri
- Connecticut
- South Carolina
- Oregon
- Louisiana
- Alabama
- Kentucky
- Rest of United States
All the Key players have been covered from 5 Viewpoints:
- Overviews
- Key Person
- Recent Developments
- SWOT Analysis
- Revenue Analysis
Company Analysis:
- GE Healthcare
- Healthcare Hologic Inc.
- Butterfly Network
- Hitachi Healthcare Americas
- Samsung Electronics Co.Ltd
- Hologic, Inc.
- Fujifilm Holdings Corporation
Table of Contents
1. Introduction3. Executive Summary
2. Research & Methodology
4. Market Dynamics
5. United States Ultrasound Devices Market
6. Market Share Analysis
7. Products
8. Portability
9. Application
10. End-user
11. States
12. Porter’s Five Analysis
13. SWOT Analysis
14. Key Players Analysis
Companies Mentioned
- GE Healthcare
- Healthcare Hologic Inc.
- Butterfly Network
- Hitachi Healthcare Americas
- Samsung Electronics Co.Ltd
- Hologic, Inc.
- Fujifilm Holdings Corporation
Methodology
In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.
Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.
Primary Research
The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:
- Validates and improves the data quality and strengthens research proceeds
- Further develop the analyst team’s market understanding and expertise
- Supplies authentic information about market size, share, growth, and forecast
The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:
- Chief executives and VPs of leading corporations specific to the industry
- Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
- Key opinion leaders (KOLs)
Secondary Research
The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Patent and regulatory databases for understanding of technical & legal developments
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic new articles, webcasts, and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | April 2026 |
| Forecast Period | 2025 - 2034 |
| Estimated Market Value ( USD | $ 2.73 Billion |
| Forecasted Market Value ( USD | $ 4.32 Billion |
| Compound Annual Growth Rate | 5.2% |
| Regions Covered | United States |
| No. of Companies Mentioned | 7 |
